FDA Determines MOBIC Tablets Were Not Withdrawn for Safety or Effectiveness
April 19, 2025
April 19, 2025
WASHINGTON, April 19 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration (FDA) has announced that it has determined that MOBIC (meloxicam) tablets, 7.5 milligrams (mg) and 15 mg, were not withdrawn from sale for reasons of safety or effectiveness.
This decision means that the FDA will not proceed with procedures to withdraw approval for abbreviated new drug applications (ANDAs) referring to this drug product. The agency will also continue approv . . .
This decision means that the FDA will not proceed with procedures to withdraw approval for abbreviated new drug applications (ANDAs) referring to this drug product. The agency will also continue approv . . .